Researchers from the Massachusetts Institute of Technology (MIT) have revealed that a new type of nanoparticle could be used to improve the delivery and immune responses of vaccines...
Jaklenec Group's News
Numerous vaccines, such as those for whooping cough and hepatitis B, contain bits of bacterial or viral proteins. These vaccines also often contain adjuvants, which are molecules that help enhance the response of the immune system to the...
In a landmark breakthrough, scientists at the Massachusetts Institute of Technology have unveiled a pioneering approach to vaccine development with the potential to reshape the landscape of preventive medicine...
Zeolitic imidazolate frameworks boost SARS-CoV-2 spike protein trimer immunity via Toll-like receptor activation...
Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose...
Vaccines are one of the best scientific discoveries because they prevent the incidence of some of the deadliest diseases. The medical field has been using them to prevent smallpox, tuberculosis, and even cancer. A recent study...
In the heart of Cambridge, Massachusetts, a groundbreaking discovery has emerged from the laboratories of the Massachusetts Institute of Technology (MIT). A team of scientists, driven by curiosity and an unyielding commitment to public health, has unlocked a new...
Nanomaterials offer unique opportunities to engineer immunomodulatory activity. In this work, we report the Toll-like receptor agonist activity of a nanoscale adjuvant zeolitic imidazolate framework–8 (ZIF-8)...
Scientists from the Massachusetts Institute of Technology (MIT) and elsewhere have published a paper in Science Advances that describes a type of nanoparticle for delivering vaccines called a metal organic...
The National Academy of Inventors recently announced its 2023 class of fellows, which includes four American Society for Biochemistry and Molecular Biology Members: Ana Jaklenec...
- 1 of 6
- Next ›